These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37342848)

  • 21. Rare case of severe cholangiopathy following critical illness.
    Patel KV; Zaman S; Chang F; Wilkinson M
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25270153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-COVID-19 Secondary Sclerosing Cholangitis: A Rare but Severe Condition with no Treatment Besides Liver Transplantation.
    Cesar Machado MC; Filho RK; El Bacha IAH; de Oliveira IS; Ribeiro CMF; de Souza HP; Parise ER
    Am J Case Rep; 2022 Aug; 23():e936250. PubMed ID: 35978523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary sclerosing cholangitis after critical COVID-19: Three case reports.
    Mayorquín-Aguilar JM; Lara-Reyes A; Revuelta-Rodríguez LA; Flores-García NC; Ruiz-Margáin A; Jiménez-Ferreira MA; Macías-Rodríguez RU
    World J Hepatol; 2022 Aug; 14(8):1678-1686. PubMed ID: 36157873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on Sclerosing Cholangitis in Critically Ill Patients.
    Kirchner GI; Rümmele P
    Viszeralmedizin; 2015 Jun; 31(3):178-84. PubMed ID: 26468312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies.
    Bartoli A; Cursaro C; Andreone P
    Curr Opin Gastroenterol; 2022 Mar; 38(2):89-97. PubMed ID: 35098930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-COVID-19 Cholestasis: A Case Series and Review of Literature.
    Kulkarni AV; Khelgi A; Sekaran A; Reddy R; Sharma M; Tirumalle S; Gora BA; Somireddy A; Reddy J; Menon B; Reddy DN; Rao NP
    J Clin Exp Hepatol; 2022; 12(6):1580-1590. PubMed ID: 35719861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19.
    Bütikofer S; Lenggenhager D; Wendel Garcia PD; Maggio EM; Haberecker M; Reiner CS; Brüllmann G; Buehler PK; Gubler C; Müllhaupt B; Jüngst C; Morell B
    Liver Int; 2021 Oct; 41(10):2404-2417. PubMed ID: 34018314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection.
    Edwards K; Allison M; Ghuman S
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33168538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Endoscopic Retrograde Cholangiopancreatography in the Diagnosis and Management of Cholestatic Liver Diseases.
    Keihanian T; Barakat MT; Tejaswi S; Mishra R; Carlson CJ; Brandabur JJ; Girotra M
    Clin Liver Dis; 2022 Feb; 26(1):51-67. PubMed ID: 34802663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent Cholestatic Injury and Secondary Sclerosing Cholangitis in COVID-19 Patients.
    Shih AR; Hatipoglu D; Wilechansky R; Goiffon R; Deshpande V; Misdraji J; Chung RT
    Arch Pathol Lab Med; 2022 Oct; 146(10):1184-1193. PubMed ID: 35657750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of portal cavernoma cholangiopathy.
    Kumar M; Saraswat VA
    J Clin Exp Hepatol; 2014 Feb; 4(Suppl 1):S62-6. PubMed ID: 25755597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AIDS Cholangiopathy.
    Yusuf TE; Baron TH
    Curr Treat Options Gastroenterol; 2004 Apr; 7(2):111-117. PubMed ID: 15010025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-Associated Cast-Forming Cholangiopathy: A Commentary on Disease Mechanism, Treatment, and Prognosis.
    Sarkis Y; Saleem N; Vuppalanchi R; Gromski M
    Hepat Med; 2023; 15():27-32. PubMed ID: 37013139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-COVID-19 cholangiopathy: Systematic review.
    Rasheed MA; Ballotin VR; Bigarella LG; Soldera J
    World J Methodol; 2023 Sep; 13(4):296-322. PubMed ID: 37771872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical management of portal cavernoma cholangiopathy.
    Varma V; Behera A; Kaman L; Chattopadhyay S; Nundy S
    J Clin Exp Hepatol; 2014 Feb; 4(Suppl 1):S77-84. PubMed ID: 25755599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of patients with ischemic-like cholangiopathy with secondary sclerosing cholangitis after liver transplantation.
    Kirchner GI; Scherer MN; Obed A; Ruemmele P; Wiest R; Froh M; Loss M; Schlitt HJ; Schölmerich J; Gelbmann CM
    Scand J Gastroenterol; 2011 Apr; 46(4):471-8. PubMed ID: 21114429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary sclerosing cholangitis: pathogenesis, diagnosis, and management.
    Imam MH; Talwalkar JA; Lindor KD
    Clin Liver Dis; 2013 May; 17(2):269-77. PubMed ID: 23540502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.
    Saffioti F; Gurusamy KS; Hawkins N; Toon CD; Tsochatzis E; Davidson BR; Thorburn D
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011343. PubMed ID: 28417463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic failure after injury - a common pathogenesis with sclerosing cholangitis?
    Zilkens C; Friese J; Köller M; Muhr G; Schinkel C
    Eur J Med Res; 2008 Jul; 13(7):309-13. PubMed ID: 18700186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholangiopathy as part of post-COVID syndrome.
    Rojas M; Rodríguez Y; Zapata E; Hernández JC; Anaya JM
    J Transl Autoimmun; 2021; 4():100116. PubMed ID: 34485887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.